Filing Flows › Comparisons › QDEL vs NEOG
QuidelOrtho vs Neogen: QDEL and NEOG compared
QuidelOrtho is the larger company: $619M of revenue in its latest quarter (Q3 2026) against $223M for Neogen (Q1 FY27). Neogen is growing faster (+6% against -12% a year earlier). Neogen is more profitable, with an operating margin of -0.8% against -1.2%.
Where the money goes: QDEL and NEOG
QuidelOrtho (QDEL) · Q3 2026
QuidelOrtho, Q3 2026: revenue $619M (-12% year over year), operating margin -1.2%, net loss $53.8M, operating cash flow $19.6M. The chart follows the revenue to costs, profit and cash.
Neogen (NEOG) · Q1 FY27
Neogen, Q1 FY27: revenue $223M (+6% year over year), operating margin -0.8%, net loss $11.9M, operating cash flow $12.9M. The chart follows the revenue to costs, profit and cash.
| QuidelOrtho (QDEL) | Neogen (NEOG) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q1 FY27 |
| Revenue | $619M | $223M |
| Revenue growth, Y/Y | -12% | +6% |
| Operating margin | -1.2% | -0.8% |
| Net earnings | −$53.8M | −$11.9M |
| Net margin | -8.7% | -5.3% |
| Operating cash flow | $19.6M | $12.9M |
| Free cash flow | $300K | $4.7M |
| Market value | $735M | $2.6B |
| Analysts’ mean target | $14.67 | $14.00 |
Where the revenue comes from
Neogen
- Product: $196M (88%)
- Service: $26.8M (12%)
Questions
Which is bigger, QuidelOrtho or Neogen?
QuidelOrtho is the larger company: $619M of revenue in its latest quarter (Q3 2026) against $223M for Neogen (Q1 FY27).
Is QuidelOrtho or Neogen growing faster?
Neogen is growing faster (+6% against -12% a year earlier).
Which is more profitable, QuidelOrtho or Neogen?
Neogen is more profitable, with an operating margin of -0.8% against -1.2%.
More: QuidelOrtho earnings · how QuidelOrtho makes money · Neogen earnings · how Neogen makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Oct 7, 2026). Fiscal quarters can end on different dates. Not investment advice.